Rare diseases
Investigational molecules
Locations
Back to Estonia148 clinical trials in Tallin, Estonia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in EstoniaKliinilisedUuringud.ee(opens in a new tab)Study on Tildrakizumab for Patients with Active Psoriatic Arthritis Who Have Previously Used Anti-TNF Therapy
EstoniaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
EstoniaStudy on the Effects of MORF-057 for Adults with Moderate to Severe Ulcerative Colitis
EstoniaStudy Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment
EstoniaStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
EstoniaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
EstoniaStudy of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab
EstoniaEfficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40
EstoniaEvaluation of Safety and Efficacy of Zilovertamab Vedotin and Nemtabrutinib in Aggressive and Indolent B-cell Malignancies
EstoniaEstoniaComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
EstoniaStudy comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy
EstoniaThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on innovative treatments for ulcerative colitis, specifically targeting patients with mild to moderate left-sided manifestations of the condition. The research explores new therapeutic approaches using targeted delivery methods.
These trials aim to evaluate the effectiveness of a new localized treatment approach compared to placebo, potentially offering improved options for patients with inflammatory bowel conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
